Primary record
N-[(1S,2R)-3-[[[4-(Hydroxymethyl)phenyl]sulfonyl](2-methylpropyl)amino]-1-benzyl-2-hydroxypropyl]carbamic acid 3,3aalpha,4,5,6,6aalpha-hexahydro-2H-cyclopenta[b]furan-5beta-yl ester
- 库存
- 2,698 克
- 纯度
- 99.6 %
- CAS
- 910909-89-6
化合物标识与属性
- CAS
- 910909-89-6
- PubChem CID
- 9547976
- SMILES
- CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@@H]2C[C@@H]3CCO[C@@H]3C2)O)S(=O)(=O)C4=CC=C(C=C4)CO
- Canonical SMILES
- CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@@H]1C[C@@H]2CCO[C@@H]2C1)S(=O)(=O)c1ccc(CO)cc1
名称与同义词
- 2hb3
- GRL-06579A
- HCT9829NJK
- RefChem:922514
- D00FEA
- UNII-HCT9829NJK
- GRL06579A
- CHEMBL254349
- GRL 06579A
- SCHEMBL13345934
- BDBM13925
- CHEBI:46414
- GRL-0036A
- GRL-216
- GRL-246
- GRL-286
- GRL-396
- GRL-1388
- GRL-1398
- GRL-02031
- GRL-98065
- CID9547976
- J2.467.299I
- hexahydrocyclopenta[b]furanyl urethane analog 3
- G31, Purdue University/NCI/Kumamoto University
- N-s-butyl-N-[(2R,3S)-3-({[(3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yloxy]carbonyl}amino)-2-hydroxy-4-phenylbutyl]-4-(hydroxymethyl)benzenesulfonamide
- Q27104567
- 910909-89-6
- (3AS,5R,6AR)-HEXAHYDRO-2H-CYCLOPENTA[B]FURAN-5-YL (2S,3S)-3-HYDROXY-4-(4-(HYDROXYMETHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYLBUTAN-2-YLCARBAMATE
- (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl {(1S,2R)-1-benzyl-2-hydroxy-3-[{[4-(hydroxymethyl)phenyl]sulfonyl}(2-methylpropyl)amino]propyl}carbamate
- HIV-1 protease inhibitors, Purdue University/NCI/Kumamoto University
- (3aS,5R,6aR)-Hexahydro-2H-cyclopenta(b)furan-5-yl N-((1S,2R)-2-hydroxy-3-(((4-(hydroxymethyl)phenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)propyl)carbamate
- (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl {(2S,3R)-3-hydroxy-4-[{[4-(hydroxymethyl)phenyl]sulfonyl}(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate
- [(3As,5R,6aR)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]furan-5-yl] N-[(2S,3R)-3-hydroxy-4-[[4-(hydroxymethyl)phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]carbamate
- Carbamic acid, ((1S,2R)-2-hydroxy-3-(((4-(hydroxymethyl)phenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)propyl)-, (3aS,5R,6aR)-hexahydro-2H-cyclopenta(b)furan-5-yl ester
- Carbamic acid, N-((1S,2R)-2-hydroxy-3-(((4-(hydroxymethyl)phenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)propyl)-, (3aS,5R,6aR)-hexahydro-2H-cyclopenta(b)furan-5-yl ester
- GRL
- (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-(hydroxymethyl)benzenesulfonamido]-1-phenylbutan-2-yl]carbamate
- (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl N-[(2S,3R)-3-hydroxy-4-{[4-(hydroxymethyl)benzene](2-methylpropyl)sulfonamido}-1-phenylbutan-2-yl]carbamate
- [(3aS,5R,6aR)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]furan-5-yl] N-[(1S,2R)-1-benzyl-2-hydroxy-3-[[4-(hydroxymethyl)phenyl]sulfonyl-isobutyl-amino]propyl]carbamate
- Carbamic acid, [(1S,2R)-2-hydroxy-3-[[[4-(hydroxymethyl)phenyl]sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-, (3aS,5R,6aR)-hexahydro-2H-cyclopenta[b]furan-5-yl ester
- G31
- N-[(1S,2R)-3-[[[4-(Hydroxymethyl)phenyl]sulfonyl](2-methylpropyl)amino]-1-benzyl-2-hydroxypropyl]carbamic acid 3,3aalpha,4,5,6,6aalpha-hexahydro-2H-cyclopenta[b]furan-5beta-yl ester